Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
Shanghaitech University has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 6 examiners and 6 art units, creating a fully distributed current docket across both dimensions. Counsel should maintain a common technical and claim strategy while preparing responses for distinct examination contexts.
SPENCER, ANDREA LYNNE MORRIS is the busiest examiner, with 1 pending matter. Since the busiest examiner has only 1 assignment, no examiner concentration is shown. Docket control and matter-specific prosecution analysis are therefore central practical priorities.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPENCER, ANDREA LYNNE MORRIS | 1 | 20.0% | +37.5% |
| ENGLISH, CONNOR KENNEDY | 1 | 59.3% | +50.3% |
| ZENG, WENWEI | 1 | 0.0% | +0.0% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 63.9% | +18.1% |
| DENT, ALANA HARRIS | 1 | 44.1% | +32.2% |
| KONOPKA, CATHERINE ANNE | 1 | 57.5% | +66.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | — |
| 18387463 | HIGH-EFFICIENT QUANTIZATION METHOD FOR DEEP PROBABILISTIC NETWORK | ZENG, WENWEI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | — |
| 18689031 | PROTEIN DEGRADATION COMPOUND BASED ON NAMPT TARGET PROTEIN AND APPLICATION THEREOF | ENGLISH, CONNOR KENNEDY | — |
| 18553729 | GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES | POLIAKOVA-GEORGAN, EKATERINA | — |
| 17921856 | DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF PIWI AND/OR NMD COMPLEX PROTEIN | DENT, ALANA HARRIS | — |
| 17822418 | COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS | KONOPKA, CATHERINE ANNE | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| 1625 | 1 |
| 2146 | 1 |
| 1637 | 1 |
| 1643 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18689031 | PROTEIN DEGRADATION COMPOUND BASED ON NAMPT TARGET PROTEIN AND APPLICATION THEREOF | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18387463 | HIGH-EFFICIENT QUANTIZATION METHOD FOR DEEP PROBABILISTIC NETWORK | ZENG, WENWEI | 2146 | §101§103 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18553729 | GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | Oct 02, 2023 |
| 17921856 | DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF PIWI AND/OR NMD COMPLEX PROTEIN | DENT, ALANA HARRIS | 1643 | §112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17822418 | COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS | KONOPKA, CATHERINE ANNE | 1635 | §103 | Final Rejection | — | Pending | Aug 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghaitech University has 6 pending office actions as of October 2026, spread across 6 art units and 6 examiners.
Andrea Lynne Morris Spencer has the most, with 1 of Shanghaitech University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
